Sep 30, 2013

Neurocrine Biosciences Q3 2013 Earnings Report

Total Revenue
$729K
Previous year: $9.36M
-92.2%
EPS
-$0.17
Previous year: -$0.05
+240.0%
Gross Profit
$729K
Previous year: $9.36M
-92.2%
Cash and Equivalents
$34.9M
Previous year: $44.5M
-21.6%
Free Cash Flow
-$10.8M
Previous year: -$8.64M
+25.2%
Total Assets
$166M
Previous year: $193M
-14.1%

Neurocrine Biosciences

Neurocrine Biosciences